Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Nathan

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Pacing and Clinical Electrophysiology : PACE|January 1, 1991
The right ventricular outflow tract as an alternative permanent pacing site: long-term follow-upE S Barin, S M Jones, D E Ward, et al.
British Journal of Clinical Pharmacology|March 1, 1990
An acute study of the electrophysiological and haemodynamic effects of intravenous UK-52,046, a novel alpha 1-adrenoceptor antagonistE S Barin, C K Wong, J E Elstob, et al.
European Heart Journal|February 1, 1983
A comparison of the antiarrhythmic effects on AV junctional re-entrant tachycardia of oral and intravenous flecainide acetateR S Bexton, K J Hellestrand, A W Nathan, et al.
Lancet (London, England)|June 9, 1984
Catheter ablation of atrioventricular conductionA W Nathan, D H Bennett, D E Ward, et al.
Drugs|January 1, 1985
The proarrhythmic effects of flecainideA W Nathan, K J Hellestrand, R S Bexton, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1983
Retrograde gap in fast pathway conduction accentuated by the class I antiarrhythmic agent, flecainideR S Bexton, K J Hellestrand, A W Nathan, et al.
The American Journal of Cardiology|March 1, 1983
Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardiasK J Hellestrand, A W Nathan, R S Bexton, et al.
Clinical Cardiology|January 1, 1982
Initial experience with a fully implantable, programmable, scanning, extrastimulus pacemaker for tachycardia terminationA W Nathan, A J Camm, R S Bexton, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1983
Systemic lupus erythematosus and IgA deficiencyV Yewdall, J S Cameron, A W Nathan, et al.
Medical & Biological Engineering & Computing|January 1, 1984
A microcomputer-based system to evaluate cardiac pacing for the treatment of tachycardiasT Cochrane, A W Nathan, R S Bexton, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Pacing and Clinical Electrophysiology : PACE|January 1, 1991
The right ventricular outflow tract as an alternative permanent pacing site: long-term follow-upE S Barin, S M Jones, D E Ward, et al.
British Journal of Clinical Pharmacology|March 1, 1990
An acute study of the electrophysiological and haemodynamic effects of intravenous UK-52,046, a novel alpha 1-adrenoceptor antagonistE S Barin, C K Wong, J E Elstob, et al.
European Heart Journal|February 1, 1983
A comparison of the antiarrhythmic effects on AV junctional re-entrant tachycardia of oral and intravenous flecainide acetateR S Bexton, K J Hellestrand, A W Nathan, et al.
Lancet (London, England)|June 9, 1984
Catheter ablation of atrioventricular conductionA W Nathan, D H Bennett, D E Ward, et al.
Drugs|January 1, 1985
The proarrhythmic effects of flecainideA W Nathan, K J Hellestrand, R S Bexton, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1983
Retrograde gap in fast pathway conduction accentuated by the class I antiarrhythmic agent, flecainideR S Bexton, K J Hellestrand, A W Nathan, et al.
The American Journal of Cardiology|March 1, 1983
Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardiasK J Hellestrand, A W Nathan, R S Bexton, et al.
Clinical Cardiology|January 1, 1982
Initial experience with a fully implantable, programmable, scanning, extrastimulus pacemaker for tachycardia terminationA W Nathan, A J Camm, R S Bexton, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1983
Systemic lupus erythematosus and IgA deficiencyV Yewdall, J S Cameron, A W Nathan, et al.
Medical & Biological Engineering & Computing|January 1, 1984
A microcomputer-based system to evaluate cardiac pacing for the treatment of tachycardiasT Cochrane, A W Nathan, R S Bexton, et al.
Pageof 8